Literature DB >> 16963244

Omega-3 fatty acids and monoamine neurotransmission.

Sylvie Chalon1.   

Abstract

We proposed several years ago that the behavioral effects of n-3 PUFA deficiency observed in animal models might be mediated through the dopaminergic and serotonergic systems that are very involved in the modulation of attention, motivation and emotion. We evaluated this hypothesis in an extended series of experiments on rats chronically diet-deficient in alpha-linolenic acid, the precursor of long-chain n-3 PUFA, in which we studied several parameters of these neurotransmission systems. The present paper synthesizes the main data we obtained on interactions between n-3 PUFA status and neurotransmission in animal models. We demonstrated that several parameters of neurotransmission were affected, such as the vesicular pool of dopamine and serotonin, thus inducing several regulatory processes such as modification of cerebral receptors in specific brain areas. We also demonstrated that (i) a reversal diet with adequate n-6 and n-3 PUFA given during the lactating period to rats originating from alpha-linolenic acid-deficient dams was able to restore both the fatty acid composition of brain membranes and several parameters of the dopaminergic and serotonergic neurotransmission, and (ii) when given from weaning, this reversal diet allowed partial recovery of biochemical parameters, but no recovery of neurochemical factors. The occurrence of profound n-3 PUFA deficiency during the lactating period could therefore be an environmental insult leading to irreversible damage to specific brain functions. Strong evidence is now showing that a profound n-3 PUFA experimental deficiency is able to alter several neurotransmission systems, at least the dopaminergic and serotonergic. Whether these experimental findings can be transposed to human pathophysiology must be taken cautiously, but reinforces the hypothesis that strong links exist between the PUFA status, aspects of brain function such as neurotransmission processes and behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963244     DOI: 10.1016/j.plefa.2006.07.005

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  114 in total

1.  The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.

Authors:  K Nakamoto; T Nishinaka; N Sato; F Aizawa; T Yamashita; M Mankura; Y Koyama; F Kasuya; S Tokuyama
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia.

Authors:  Korapat Mayurasakorn; Jill J Williams; Vadim S Ten; Richard J Deckelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

Review 3.  Omega-3 fatty acids for depression in adults.

Authors:  Katherine M Appleton; Hannah M Sallis; Rachel Perry; Andrew R Ness; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2015-11-05

4.  Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial.

Authors:  Marlene P Freeman; Joseph R Hibbeln; Michael Silver; April M Hirschberg; Betty Wang; Amy M Yule; Laura F Petrillo; Erica Pascuillo; Nicole I Economou; Hadine Joffe; Lee S Cohen
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

5.  Effect of diet on brain metabolites and behavior in spontaneously hypertensive rats.

Authors:  Ana A Liso Navarro; Elif M Sikoglu; Cailin R Heinze; Ryan C Rogan; Vivienne A Russell; Jean A King; Constance M Moore
Journal:  Behav Brain Res       Date:  2014-05-19       Impact factor: 3.332

6.  Smoking and red blood cell phospholipid membrane fatty acids.

Authors:  H J Murff; H A Tindle; M J Shrubsole; Q Cai; W Smalley; G L Milne; L L Swift; R M Ness; W Zheng
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-08-16       Impact factor: 4.006

Review 7.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

8.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

9.  Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.

Authors:  Sarah A Keim; Kelly M Boone; Mark A Klebanoff; Abigail Norris Turner; Joseph Rausch; Mary Ann Nelin; Lynette K Rogers; Keith Owen Yeates; Leif Nelin; Kelly W Sheppard
Journal:  JAMA Pediatr       Date:  2018-12-01       Impact factor: 16.193

10.  The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.

Authors:  Murat Oz; Vanaja Jaligam; Sehamuddin Galadari; George Petroianu; Yaroslav M Shuba; Toni S Shippenberg
Journal:  J Neurochem       Date:  2009-12-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.